Regenerative Medicine: Regulatory, Legal, and Compliance Challenges for Cell and Gene Therapies - FDLI
Jun 8 2021
11:00 AM - 11:45 AM
Barbara Binzak Blumenfeld, shareholder in the firm's Life Sciences Industry Group, moderated a panel at the Food and Drug Law Institute’s conference on “Regenerative Medicine: Regulatory, Legal, and Compliance Challenges for Cell and Gene Therapies.” Barbara’s panel, “Bonus Session: A Primer on Regenerative Medicine Science and Recent Breakthroughs,” discussed key examples of regenerative medicine products and technologies, including recent FDA approvals. More information about the conference can be found here.